REGN MACD
As of date:11/25/2022
REGN stock price:736.23
REGN 50 DMA:728.00
REGN 200 DMA:659.55
REGN MACD (200-50):-68.45

Also see:
REGN Market Cap History
REGN Shares Outstanding History
REGN YTD Return
REGN DMA
REGN RSI
REGN Technical Analysis

Try ChartSweeps today

Alexander's (ALX) Shares Cross Below 200 DMA
12 minutes ago


Bullish Two Hundred Day Moving Average Cross - RUP.CA
12 minutes ago


Shares of KCCA Now Oversold
12 minutes ago


Bullish Two Hundred Day Moving Average Cross - FLIC
Wednesday, November 23, 4:30 PM


NovaGold Resources Breaks Above 200-Day Moving Average - Bullish for NG
Wednesday, November 23, 4:23 PM


Bullish Two Hundred Day Moving Average Cross - VST
Wednesday, November 23, 4:14 PM


Bullish Two Hundred Day Moving Average Cross - WPM
Wednesday, November 23, 4:08 PM


TILT Makes Bullish Cross Above Critical Moving Average
Wednesday, November 23, 4:06 PM


Bullish Two Hundred Day Moving Average Cross - RELX
Wednesday, November 23, 4:06 PM


FLCA Shares Cross Above 200 DMA
Wednesday, November 23, 4:05 PM


Abercrombie & Fitch (ANF) Shares Cross Above 200 DMA
Wednesday, November 23, 4:05 PM


CAL Makes Notable Cross Below Critical Moving Average
Wednesday, November 23, 4:05 PM


IMTM Crosses Above Key Moving Average Level
Wednesday, November 23, 4:05 PM


EFAX Makes Bullish Cross Above Critical Moving Average
Wednesday, November 23, 4:05 PM


Invesco RAFI Strategic Developed ex-US (ISDX) Shares Cross Above 200 DMA
Wednesday, November 23, 4:05 PM


More Technical Analysis News

REGN MACDREGN DMA
Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

When researching a stock like Regeneron Pharmaceuticals, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from REGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for REGN stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the REGN 200 day moving average ("REGN 200 DMA"), while one of the most popular "shorter look-backs" is the REGN 50 day moving average ("REGN 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Regeneron Pharmaceuticals. Comparing two moving averages against each other can be a useful visualization tool: by calculating the difference between the REGN 200 DMA and the REGN 50 DMA, we get a moving average convergence divergence indicator ("REGN MACD"). The REGN MACD chart, in conjunction with the chart of the moving averages, basically helps in visualizing how the moving averages are showing convergence (moving closer together), or divergence (moving farther apart).
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree REGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Regeneron Pharmaceuticals (REGN) is categorized under the Healthcare sector; to help you further research MACD, below are some other companies in the same sector:

RMD MACD
STE MACD
SYK MACD
TECH MACD
TFX MACD
TMO MACD
UHS MACD
VRTX MACD
VTRS MACD
WAT MACD
More Healthcare companies »

 

REGN MACD | www.StockMACD.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in StockMACD.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.